| Ticker Details |
|
PDS Biotechnology Corporation
|
| IPO Date: |
October 2, 2015 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$59.72M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.19 | 4.18%
|
| Avg Daily Range (30 D): |
$0.04 | 5.93%
|
| Avg Daily Range (90 D): |
$0.04 | 4.63%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.57M |
| Avg Daily Volume (30 D): |
.48M |
| Avg Daily Volume (90 D): |
.51M |
| Trade Size |
| Avg Trade Size (Sh.): |
184 |
| Avg Trade Size (Sh.) (30 D): |
321 |
| Avg Trade Size (Sh.) (90 D): |
323 |
| Institutional Trades |
| Total Institutional Trades: |
26 |
| Avg Institutional Trade: |
$1.98M |
| Avg Institutional Trade (30 D): |
$1.59M |
| Avg Institutional Trade (90 D): |
$1.59M |
| Avg Institutional Trade Volume: |
.42M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$3.99M |
| Avg Closing Trade (30 D): |
$.72M |
| Avg Closing Trade (90 D): |
$.72M |
| Avg Closing Volume: |
791.96K |
|
|
| Financials |
| |
TTM |
Q4 2025 |
FY 2025 |
|
Basic EPS
|
$-.74
|
$-.14
|
$-.74
|
|
Diluted EPS
|
$-.74
|
$-.14
|
$-.74
|
|
Revenue
|
$M
|
$M
|
$M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-34.5M
|
$-7.56M
|
$-34.5M
|
|
Operating Income / Loss
|
$-31.54M
|
$-6.67M
|
$-31.54M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$M
|
$M
|
$M
|
|
PE Ratio
|
|
|
|
|
|
|